AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Tits, L. J
Right arrow Articles by Stalenhoef, A. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Tits, L. J
Right arrow Articles by Stalenhoef, A. F
Agricola
Right arrow Articles by van Tits, L. J
Right arrow Articles by Stalenhoef, A. F
American Journal of Clinical Nutrition, Vol. 71, No. 2, 458-464, February 2000
© 2000 American Society for Clinical Nutrition


Original Research Communications

{alpha}-Tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals1,2

Lambertus J van Tits, Pierre N Demacker, Jacqueline de Graaf, Heidi L Hak-Lemmers and Anton F Stalenhoef

1 From the Department of Medicine, Division of General Internal Medicine, University Hospital Nijmegen, Nijmegen, Netherlands.

Background: {alpha}-Tocopherol plays an important role in protecting LDL against oxidation. However, additional effects of {alpha}-tocopherol at the intracellular level may contribute to the clinical outcome of intervention studies.

Objective: We investigated whether {alpha}-tocopherol influences the inflammatory responses of immune cells in normolipidemic and hypertriglyceridemic subjects.

Design: RRR-{alpha}-Tocopherol was administered for 6 wk at a dose of 600 IU (402 mg)/d to 12 primary hypertriglyceridemic and 8 normolipidemic (fasting triacylglycerol >3.0 and <2.0 mmol/L, respectively) subjects. Cytokine production [tumor necrosis factor {alpha} (TNF-{alpha}), interleukin (IL)-1ß, and IL-8] by mononuclear cells and superoxide production by polymorphonuclear cells and in diluted whole blood were determined before and after the intervention.

Results: Cytokine and superoxide production did not differ significantly between hypertriglyceridemic and normolipidemic subjects. {alpha}-Tocopherol supplementation resulted in a 2- to 3-fold increase in the concentration of {alpha}-tocopherol in plasma and LDL. Whereas superoxide production in response to phorbol 12-myristate 13-acetate decreased in all subjects, response to oxidized LDL increased in 19 of 20 subjects. Response to opsonized zymosan before {alpha}-tocopherol supplementation was not significantly different from that after supplementation. Lipopolysaccharide-induced cytokine production by mononuclear cells decreased after supplementation with {alpha}-tocopherol.

Conclusions: {alpha}-Tocopherol differentially influences inflammatory responses of immune cells. These effects of {alpha}-tocopherol may be relevant in chronic inflammatory processes such as atherogenesis.

Key Words: {alpha}-Tocopherol • superoxide • chemiluminescence • cytokines • oxidized LDL • hypertriglyceridemia • men • reactive oxygen species • antioxidants




This article has been cited by other articles:


Home page
J. Nutr.Home page
S. E. Belisle, L. S. Leka, J. Delgado-Lista, P. F. Jacques, J. M. Ordovas, and S. N. Meydani
Polymorphisms at Cytokine Genes May Determine the Effect of Vitamin E on Cytokine Production in the Elderly
J. Nutr., October 1, 2009; 139(10): 1855 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. Sundl, M. Guardiola, G. Khoschsorur, R. Sola, J. C. Vallve, G. Godas, L. Masana, M. Maritschnegg, A. Meinitzer, N. Cardinault, et al.
Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene 1131T>C variant and associations with plasma lipids and lipid peroxidation
J. Lipid Res., November 1, 2007; 48(11): 2506 - 2513.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
U. Singh, J. Tabibian, S. K. Venugopal, S. Devaraj, and I. Jialal
Development of an In Vitro Screening Assay to Test the Antiinflammatory Properties of Dietary Supplements and Pharmacologic Agents
Clin. Chem., December 1, 2005; 51(12): 2252 - 2256.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. L. Hall, Y. M. Jeanes, and J. K. Lodge
Hyperlipidemic Subjects Have Reduced Uptake of Newly Absorbed Vitamin E into Their Plasma Lipoproteins, Erythrocytes, Platelets, and Lymphocytes, as Studied by Deuterium-Labeled {alpha}-Tocopherol Biokinetics
J. Nutr., January 1, 2005; 135(1): 58 - 63.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
A. Dutta and S. K. Dutta
Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review
J. Am. Coll. Nutr., August 1, 2003; 22(4): 258 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Bruunsgaard, H. E. Poulsen, B. K. Pedersen, K. Nyyssonen, J. Kaikkonen, and J. T. Salonen
Long-Term Combined Supplementations with {alpha}-Tocopherol and Vitamin C Have No Detectable Anti-Inflammatory Effects in Healthy Men
J. Nutr., April 1, 2003; 133(4): 1170 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. Jialal, S. Devaraj, and N. Kaul
The Effect of {{alpha}}-Tocopherol on Monocyte Proatherogenic Activity
J. Nutr., February 1, 2001; 131(2): 389S - 394.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The American Society for Nutrition